2-naphthol has been researched along with paclitaxel in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, CY; Coombes, RC; Di Fruscia, P; Fuchter, MJ; Ho, KK; Hsiao, CD; Lam, EW; Myatt, SS; Peck, B | 1 |
| Pal, S; Sainis, KB; Shankar, BS | 1 |
| Desai, AA; Gupta, AK; Jurewicz, K; Mohammadlou, A; Mukherjee, M; Wulff, WD; Yin, X | 1 |
3 other study(ies) available for 2-naphthol and paclitaxel
| Article | Year |
|---|---|
SIRT inhibitors induce cell death and p53 acetylation through targeting both SIRT1 and SIRT2.
Topics: Acetylation; Benzamides; Carbazoles; Cell Death; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Screening Assays, Antitumor; G1 Phase; Gene Silencing; Humans; Lysine; Models, Molecular; Naphthols; Paclitaxel; Phenylpropionates; Protein Structure, Secondary; Sirtuin 1; Sirtuin 2; Tubulin; Tumor Suppressor Protein p53 | 2010 |
Cytokines from the tumor microenvironment modulate sirtinol cytotoxicity in A549 lung carcinoma cells.
Topics: Apoptosis; Benzamides; Cell Line, Tumor; Cell Survival; Cisplatin; Cytokines; Drug Resistance, Neoplasm; ErbB Receptors; Humans; Insulin-Like Growth Factor I; Janus Kinases; Lung Neoplasms; Molecular Targeted Therapy; Naphthols; Paclitaxel; Phosphatidylinositol 3-Kinases; Receptor, IGF Type 1; Receptors, TNF-Related Apoptosis-Inducing Ligand; Receptors, Tumor Necrosis Factor; Sirtuin 1; TNF-Related Apoptosis-Inducing Ligand; Transforming Growth Factor beta; Tumor Microenvironment; Tumor Necrosis Factor-alpha; Tyrphostins | 2013 |
Catalytic Asymmetric Epoxidation of Aldehydes with Two VANOL-Derived Chiral Borate Catalysts.
Topics: Aldehydes; Aziridines; Borates; Catalysis; Diazonium Compounds; Epoxy Compounds; Molecular Structure; Naphthalenes; Naphthols; Paclitaxel; Stereoisomerism | 2019 |